Advertisement

Topics

#JPM19 Conference: Lilly Announces Agreement To Acquire Loxo Oncology


News announced during the 37th J.P. Morgan Healthcare Conference (#JPM19): Drugmaker Eli Lilly and Company announced its plans to acquire Loxo for $8 billion, as part of its oncology strategy, which focuses  “opportunities for first-in-class and best-in-class therapies.”    Reporter: Gail S. Thornton Please read their press release below. INDIANAPOLIS and STAMFORD, Conn., Jan. 7, 2019 /PRNewswire/ — Acquisition will […]

Original Article: #JPM19 Conference: Lilly Announces Agreement To Acquire Loxo Oncology

NEXT ARTICLE

More From BioPortfolio on "#JPM19 Conference: Lilly Announces Agreement To Acquire Loxo Oncology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...